Stocktoria

PULSE BIOSCIENCES, INC. PLSE

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-05-18 · LEI

PULSE BIOSCIENCES, INC. financials (annual)

Revenue
$0 $1.4M $700000 $0 $0 $350000 2016201720182019202020212022202320242025
Net income
-$9.5M -$25.6M -$37.5M -$47.0M -$49.9M -$63.7M -$58.5M -$42.2M -$53.6M -$72.8M 2016201720182019202020212022202320242025
Free cash flow
-$8.1M -$13.6M -$24.2M -$34.8M -$35.8M -$54.5M -$47.4M -$33.2M -$36.5M -$54.4M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$350,000$0$0$700,000$1.4M$0
R&D expense$44.7M$32.3M$27.8M$20.8M$28.6M$26.4M$25.0M$17.3M$9.6M$5.5M
SG&A expense$32.0M$23.9M
Operating income-$76.9M-$56.3M-$43.6M-$58.1M-$63.0M-$50.0M-$48.0M-$37.5M-$25.6M-$9.5M
Income tax$0$0$0$0$0$0
Net income-$72.8M-$53.6M-$42.2M-$58.5M-$63.7M-$49.9M-$47.0M-$37.5M-$25.6M-$9.5M
Operating cash flow-$54.1M-$36.3M-$33.0M-$47.0M-$54.1M-$35.4M-$34.2M-$23.9M-$11.1M-$8.1M
Free cash flow-$54.4M-$36.5M-$33.2M-$47.4M-$54.5M-$35.8M-$34.8M-$24.2M-$13.6M-$8.1M
Cash & equivalents$80.7M$118.0M$44.4M$61.1M$44.4M$12.5M$6.9M$51.1M$3.4M$2.1M
Inventory$136,000$0$0$5.8M
Total assets$94.5M$132.5M$59.2M$77.9M$59.2M$41.3M$41.9M$70.6M$49.8M$26.3M
Total liabilities$13.9M$17.6M$14.8M$80.1M$14.8M$18.4M$11.2M$4.3M$3.8M$1.0M
Shareholders' equity$80.7M$114.9M$44.4M-$2.2M$44.4M$22.9M$30.7M$66.3M$46.0M$25.3M

Growth · year-over-year

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-100.0%-50.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.